Sound waves vs. pancreatic cancer: a new hope?

NCT ID NCT07325214

First seen Jan 09, 2026 · Last updated May 15, 2026 · Updated 12 times

Summary

This study tests whether adding a focused ultrasound treatment called IMD10 to standard chemotherapy can help people with pancreatic cancer that is either borderline resectable or locally advanced. About 136 adults aged 18 to 85 with confirmed pancreatic ductal adenocarcinoma will be randomly assigned to receive chemotherapy alone or chemotherapy plus focused ultrasound. The main goal is to see if the combination helps patients live longer.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Brigham and Women's Hospital

    Boston, Massachusetts, 02115, United States

    Contact

  • Seoul National University Bundang Hospital,

    Gyeonggi-do, 13620, South Korea

    Contact

  • Seoul National University Hospital

    Seoul, 03080, South Korea

    Contact

  • University of Texas Health Science Center at San Antonio

    San Antonio, Texas, 78229, United States

    Contact

  • University of Virginia Medical Center

    Charlottesville, Virginia, 22908, United States

    Contact

Conditions

Explore the condition pages connected to this study.